<?xml version='1.0' encoding='utf-8'?>
<document id="1676629"><sentence text="Effect of H2 antagonists on the differential secretion of triamterene and its sulfate conjugate metabolite by the isolated perfused rat kidney."><entity charOffset="58-69" id="DDI-PubMed.1676629.s1.e0" text="triamterene" /><entity charOffset="78-85" id="DDI-PubMed.1676629.s1.e1" text="sulfate" /><pair ddi="false" e1="DDI-PubMed.1676629.s1.e0" e2="DDI-PubMed.1676629.s1.e0" /><pair ddi="false" e1="DDI-PubMed.1676629.s1.e0" e2="DDI-PubMed.1676629.s1.e1" /></sentence><sentence text="The isolated perfused rat kidney model was used to examine the effect of the histamine H2 antagonists cimetidine, ranitidine, and famotidine and the organic anion inhibitor probenecid on the differential renal handling of triamterene and its active metabolite p-hydroxytriamterene sulfate"><entity charOffset="77-86" id="DDI-PubMed.1676629.s2.e0" text="histamine" /><entity charOffset="102-112" id="DDI-PubMed.1676629.s2.e1" text="cimetidine" /><entity charOffset="114-124" id="DDI-PubMed.1676629.s2.e2" text="ranitidine" /><entity charOffset="130-140" id="DDI-PubMed.1676629.s2.e3" text="famotidine" /><entity charOffset="173-183" id="DDI-PubMed.1676629.s2.e4" text="probenecid" /><entity charOffset="222-233" id="DDI-PubMed.1676629.s2.e5" text="triamterene" /><entity charOffset="260-288" id="DDI-PubMed.1676629.s2.e6" text="p-hydroxytriamterene sulfate" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e0" e2="DDI-PubMed.1676629.s2.e0" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e0" e2="DDI-PubMed.1676629.s2.e1" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e0" e2="DDI-PubMed.1676629.s2.e2" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e0" e2="DDI-PubMed.1676629.s2.e3" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e0" e2="DDI-PubMed.1676629.s2.e4" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e0" e2="DDI-PubMed.1676629.s2.e5" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e0" e2="DDI-PubMed.1676629.s2.e6" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e1" e2="DDI-PubMed.1676629.s2.e1" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e1" e2="DDI-PubMed.1676629.s2.e2" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e1" e2="DDI-PubMed.1676629.s2.e3" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e1" e2="DDI-PubMed.1676629.s2.e4" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e1" e2="DDI-PubMed.1676629.s2.e5" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e1" e2="DDI-PubMed.1676629.s2.e6" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e2" e2="DDI-PubMed.1676629.s2.e2" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e2" e2="DDI-PubMed.1676629.s2.e3" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e2" e2="DDI-PubMed.1676629.s2.e4" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e2" e2="DDI-PubMed.1676629.s2.e5" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e2" e2="DDI-PubMed.1676629.s2.e6" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e3" e2="DDI-PubMed.1676629.s2.e3" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e3" e2="DDI-PubMed.1676629.s2.e4" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e3" e2="DDI-PubMed.1676629.s2.e5" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e3" e2="DDI-PubMed.1676629.s2.e6" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e4" e2="DDI-PubMed.1676629.s2.e4" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e4" e2="DDI-PubMed.1676629.s2.e5" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e4" e2="DDI-PubMed.1676629.s2.e6" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e5" e2="DDI-PubMed.1676629.s2.e5" /><pair ddi="false" e1="DDI-PubMed.1676629.s2.e5" e2="DDI-PubMed.1676629.s2.e6" /></sentence><sentence text=" The kidneys were perfused with a Krebs-Henseleit buffer containing albumin, glucose, and amino acids to pH 7"><entity charOffset="77-84" id="DDI-PubMed.1676629.s3.e0" text="glucose" /><entity charOffset="90-101" id="DDI-PubMed.1676629.s3.e1" text="amino acids" /><pair ddi="false" e1="DDI-PubMed.1676629.s3.e0" e2="DDI-PubMed.1676629.s3.e0" /><pair ddi="false" e1="DDI-PubMed.1676629.s3.e0" e2="DDI-PubMed.1676629.s3.e1" /></sentence><sentence text="4, and drug concentrations were measured by HPLC" /><sentence text=" At an initial triamterene concentration of 0"><entity charOffset="15-26" id="DDI-PubMed.1676629.s5.e0" text="triamterene" /></sentence><sentence text="5 mg/liter, the unbound renal clearance to glomerular filtration rate (GFR) ratio was 11" /><sentence text="0 +/- 2" /><sentence text="5 (mean +/- SD): 1, indicating substantial tubular secretion of the drug" /><sentence text=" Cimetidine and ranitidine reduced the tubular secretion by about 80% (p less than 0"><entity charOffset="1-11" id="DDI-PubMed.1676629.s9.e0" text="Cimetidine" /><entity charOffset="16-26" id="DDI-PubMed.1676629.s9.e1" text="ranitidine" /><pair ddi="false" e1="DDI-PubMed.1676629.s9.e0" e2="DDI-PubMed.1676629.s9.e0" /><pair ddi="false" e1="DDI-PubMed.1676629.s9.e0" e2="DDI-PubMed.1676629.s9.e1" /></sentence><sentence text="01), famotidine by between 35 and 60% (p = 0"><entity charOffset="5-15" id="DDI-PubMed.1676629.s10.e0" text="famotidine" /></sentence><sentence text="05), whereas probenecid had no inhibitory effect" /><sentence text=" For p-hydroxytriamterene sulfate, its unbound renal clearance to GFR ratio was 41 +/- 25:1; this was not affected by cimetidine, ranitidine, or famotidine, whereas probenecid significantly (p less than 0"><entity charOffset="5-33" id="DDI-PubMed.1676629.s12.e0" text="p-hydroxytriamterene sulfate" /><entity charOffset="118-128" id="DDI-PubMed.1676629.s12.e1" text="cimetidine" /><entity charOffset="130-140" id="DDI-PubMed.1676629.s12.e2" text="ranitidine" /><entity charOffset="145-155" id="DDI-PubMed.1676629.s12.e3" text="famotidine" /><pair ddi="false" e1="DDI-PubMed.1676629.s12.e0" e2="DDI-PubMed.1676629.s12.e0" /><pair ddi="false" e1="DDI-PubMed.1676629.s12.e0" e2="DDI-PubMed.1676629.s12.e1" /><pair ddi="false" e1="DDI-PubMed.1676629.s12.e0" e2="DDI-PubMed.1676629.s12.e2" /><pair ddi="false" e1="DDI-PubMed.1676629.s12.e0" e2="DDI-PubMed.1676629.s12.e3" /><pair ddi="false" e1="DDI-PubMed.1676629.s12.e1" e2="DDI-PubMed.1676629.s12.e1" /><pair ddi="false" e1="DDI-PubMed.1676629.s12.e1" e2="DDI-PubMed.1676629.s12.e2" /><pair ddi="false" e1="DDI-PubMed.1676629.s12.e1" e2="DDI-PubMed.1676629.s12.e3" /><pair ddi="false" e1="DDI-PubMed.1676629.s12.e2" e2="DDI-PubMed.1676629.s12.e2" /><pair ddi="false" e1="DDI-PubMed.1676629.s12.e2" e2="DDI-PubMed.1676629.s12.e3" /></sentence><sentence text="01) reduced the rate of tubular secretion by 80%" /><sentence text=" These data indicate that the renal tubular secretion of triamterene is mediated by the organic cation system, whereas for p-hydroxytriamterene sulfate its tubular secretion is via the organic anion system"><entity charOffset="57-68" id="DDI-PubMed.1676629.s14.e0" text="triamterene" /><entity charOffset="123-151" id="DDI-PubMed.1676629.s14.e1" text="p-hydroxytriamterene sulfate" /><pair ddi="false" e1="DDI-PubMed.1676629.s14.e0" e2="DDI-PubMed.1676629.s14.e0" /><pair ddi="false" e1="DDI-PubMed.1676629.s14.e0" e2="DDI-PubMed.1676629.s14.e1" /></sentence><sentence text=" Famotidine is a weaker inhibitor of the organic cation system compared with cimetidine and ranitidine"><entity charOffset="1-11" id="DDI-PubMed.1676629.s15.e0" text="Famotidine" /><entity charOffset="77-87" id="DDI-PubMed.1676629.s15.e1" text="cimetidine" /><entity charOffset="92-102" id="DDI-PubMed.1676629.s15.e2" text="ranitidine" /><pair ddi="false" e1="DDI-PubMed.1676629.s15.e0" e2="DDI-PubMed.1676629.s15.e0" /><pair ddi="false" e1="DDI-PubMed.1676629.s15.e0" e2="DDI-PubMed.1676629.s15.e1" /><pair ddi="false" e1="DDI-PubMed.1676629.s15.e0" e2="DDI-PubMed.1676629.s15.e2" /><pair ddi="false" e1="DDI-PubMed.1676629.s15.e1" e2="DDI-PubMed.1676629.s15.e1" /><pair ddi="false" e1="DDI-PubMed.1676629.s15.e1" e2="DDI-PubMed.1676629.s15.e2" /></sentence><sentence text=" These results have implications for drug-drug interaction studies involving renal elimination pathways" /><sentence text="" /></document>